Preeclampsia is a serious pregnancy-related hypertensive condition that can lead to complications for both the mother and baby if not detected early. It affects about 5–8% of pregnancies worldwide, especially in low-resource settings where regular advanced screening isn’t easily available. Eclara helps in early identification of preeclampsia risk using simple, routine maternal health indicators, no expensive lab tests required. To empower healthcare providers and expectant mothers with AI-assisted early detection for safer pregnancies.

Created for use by clinicians and researchers in clinical and academic environments.
Built-in logic ensures data accuracy before processing.
Patient data is securely sent to the cloud, where our backend AI models analyze it to assess risk.

The app takes basic clinical data such as:
Built-in logic ensures data accuracy before processing.


All information is used with patient consent and handled anonymously for research and improvement of maternal health outcomes.